Literature DB >> 15333335

Increase in utilization of percutaneous renal artery interventions by medicare beneficiaries, 1996-2000.

Timothy P Murphy1, Gregory Soares, Myra Kim.   

Abstract

OBJECTIVE: Our purpose was to review data from Medicare physician claims to ascertain differences in annual volumes of renal artery interventions versus surgery and differences in utilization of renal artery interventions among geographic regions according to physician provider type between 1996 and 2000.
MATERIALS AND METHODS: We analyzed claims submitted to Medicare in 1996, 1998, and 2000 and extracted claims for renal artery angioplasty, stent placement, or bypass surgery. Analyses were performed for percutaneous renal artery interventions categorized by Centers for Medicare & Medicaid Services (CMS) geographic region and physician provider type.
RESULTS: Between 1996 and 2000, the total volume of renal revascularization (surgical and percutaneous) increased 62%, from 13,380 to 21,660 procedures. The annual volume of renal artery surgery decreased 45% in 2000, compared with the volume in 1996. Annual volumes of renal artery angioplasty and stent placement increased 2.4-fold in 2000 compared with those in 1996. Most growth in percutaneous renal artery interventions is attributed to added provision by cardiologists, who increased their annual volume 3.9-fold. More than a threefold difference in rates of use of renal artery interventional procedures across CMS regions was found. In the Southeast region, the volume of renal artery interventions by cardiologists increased more than 15-fold.
CONCLUSION: Among Medicare beneficiaries, the volume of percutaneous renal artery interventions is increasing rapidly, whereas the volume of renal artery surgery is declining. Most growth in percutaneous renal artery revascularization is attributed to increased performance by cardiologists; explosive growth in annual procedure volume by cardiologists occurred in some regions. Marked disparity in use among CMS regions was found.

Entities:  

Mesh:

Year:  2004        PMID: 15333335     DOI: 10.2214/ajr.183.3.1830561

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  29 in total

1.  Statins and renovascular disease in the elderly: a population-based cohort study.

Authors:  Daniel G Hackam; Fangyun Wu; Ping Li; Peter C Austin; Sheldon W Tobe; Muhammad M Mamdani; Amit X Garg
Journal:  Eur Heart J       Date:  2010-12-14       Impact factor: 29.983

Review 2.  New guidelines for drive-by renal arteriography may lead to an unjustifiable increase in percutaneous intervention.

Authors:  James W Dear; Paul L Padfield; David J Webb
Journal:  Heart       Date:  2007-12       Impact factor: 5.994

Review 3.  [Renal artery stenosis. Pathophysiology--diagnosis--therapy].

Authors:  Heinrich Wieneke; Thomas Friedrich Michael Konorza; Holger Eggebrecht; Christoph Kurt Naber; Sebastian Philipp; Thomas Philipp; Andreas Kribben; Raimund Erbel
Journal:  Med Klin (Munich)       Date:  2009-05-16

Review 4.  Renal Artery Stenosis in Patients with Resistant Hypertension: Stent It or Not?

Authors:  Patricia Van der Niepen; Patrick Rossignol; Jean-Philippe Lengelé; Elena Berra; Pantelis Sarafidis; Alexandre Persu
Journal:  Curr Hypertens Rep       Date:  2017-01       Impact factor: 5.369

Review 5.  Endovascular Treatment of Renal Artery Stenosis in the Post CORAL Era.

Authors:  Paul J O'Connor; Robert A Lookstein
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-08

Review 6.  Update on intervention versus medical therapy for atherosclerotic renal artery stenosis.

Authors:  Albeir Y Mousa; Ali F AbuRahma; Joseph Bozzay; Mike Broce; Mark Bates
Journal:  J Vasc Surg       Date:  2015-06       Impact factor: 4.268

7.  Renovascular hypertension 2014: what have we learned from CORAL?

Authors:  S C Textor
Journal:  J Hum Hypertens       Date:  2014-06-26       Impact factor: 3.012

8.  Does Renal Artery Stenting Prevent Clinical Events?

Authors:  Stephen C Textor; Sanjay Misra
Journal:  Clin J Am Soc Nephrol       Date:  2016-05-25       Impact factor: 8.237

Review 9.  Renovascular hypertension in 2007: where are we now?

Authors:  Stephen C Textor
Journal:  Curr Cardiol Rep       Date:  2007-11       Impact factor: 2.931

Review 10.  Emerging Paradigms in Chronic Kidney Ischemia.

Authors:  Alfonso Eirin; Stephen C Textor; Lilach O Lerman
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.